US EditionVetter Pharma breaks ground US clinical manufacturing site
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
Vetter invests US$285m in Chicago production facility - European Biotechnology Magazine
CDMO and filled syringe specialist Vetter has broken the ground for a new clinical site construction in the greater Chicago area that is expected to be ready for early clinical filling by the end of 2029. The post Vetter invests US$285m in Chicago production facility appeared first on European Biotechnology Magazine.
With an official groundbreaking ceremony, Vetter kicked off the construction of its new clinical production site in the Chicago area. The state-of-the-art facility is being built in Des Plaines, Illinois, and is scheduled for completion by the end of 2029. With an investment volume of approximately €250 million...
Vetter breaks ground on $285 million clinical manufacturing site in Des Plaines
Chicago Construction News staff writer German pharmaceutical manufacturer Vetter has broken ground on a new clinical production facility in Des Plaines, marking a $285 million investment in its U.S. operations. The facility will expand the company’s capacity for early-stage, small-batch manufacturing of injectable drugs and is expected to be ready for media fill testing by the end of 2029. The 860,000-square-foot site will also include warehous…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
